ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
荃信生物-B
20.480
-0.480
-2.29%
手動刷新
成交量:
21.78萬
成交額:
444.45萬
市值:
46.08億
市盈率:
12.62
高:
20.820
開:
20.820
低:
20.100
收:
20.960
52周最高:
36.500
52周最低:
8.990
股本:
2.25億
香港流通股本:
2.25億
量比:
0.30
換手率:
0.10%
股息:
- -
股息率:
- -
每股收益(LYR):
1.622
淨資產收益率:
68.31%
總資產收益率:
15.43%
市淨率:
5.77
市盈率(LYR):
12.62
市銷率:
4.96
資料載入中...
總覽
公司
新聞資訊
公告
荃信生物-B(02509)1月29日斥資75.22萬港元回購3.5萬股
智通财经
·
01/29
每日沽空追蹤 | 荃信生物-B 01月28日沽空量成交3000股,沽空比例為0.69%
市场透视
·
01/28
荃信生物-B(02509)1月27日斥資31.98萬港元回購1.46萬股
智通财经
·
01/27
2025年中國創新藥對外授權交易額超1300億美元創紀錄
DoNews
·
01/27
智通港股回購統計|1月27日
智通财经
·
01/27
荃信生物-B(02509)1月26日耗資約195.28萬港元回購8.96萬股
智通财经
·
01/26
第一批NewCo,正在交卷
投资界
·
01/26
每日沽空追蹤 | 荃信生物-B 01月26日沽空量成交1200股,沽空比例為0.58%
市场透视
·
01/26
每日沽空追蹤 | 荃信生物-B 01月23日沽空量成交2000股,沽空比例為0.25%
市场透视
·
01/23
荃信生物-B(02509)出現大手賣出45萬股,成交價$20.0,涉資900萬
阿斯达克财经
·
01/23
荃信生物-B(02509)1月21日斥資98.88萬港元回購4.4萬股
智通财经
·
01/21
每日沽空追蹤 | 荃信生物-B 01月21日沽空量成交1600股,沽空比例為0.86%
市场透视
·
01/21
中金:首予荃信生物-B(02509)跑贏行業評級 目標價33.00港元
智通财经
·
01/21
荃信生物-B(02509)1月20日斥資183.5萬港元回購8.4萬股
中金财经
·
01/20
江蘇荃信生物醫藥(02509)回購8.4萬股股份,總額約183.53萬港元
公告速递
·
01/20
荃信生物-B(02509)1月19日斥資118.18萬港元回購5.3萬股
智通财经
·
01/19
每日沽空追蹤 | 荃信生物-B 01月19日沽空量成交800股,沽空比例為0.38%
市场透视
·
01/19
荃信生物的NewCo有點東西,投資人和高管層靠譜太重要了
Jo的随笔
·
01/17
荃信生物-B於1月15日斥資68.28萬港元回購2.96萬股
新浪港股
·
01/16
荃信生物-B(02509):QX030N/CLD-423完成I期臨床試驗首批受試者給藥 CALDERA THERAPEUTICS累計籌資1.125億美元
智通财经
·
01/14
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02509/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02509","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02509\",,,,,undefined,":{"symbol":"02509","market":"HK","secType":"STK","nameCN":"荃信生物-B","latestPrice":20.48,"timestamp":1776413294008,"preClose":20.96,"halted":0,"volume":217800,"delay":0,"changeRate":-0.022900763358778647,"floatShares":225000000,"shares":225000000,"eps":1.622238335632761,"marketStatus":"休市中","change":-0.48,"latestTime":"04-17 16:08:14","open":20.82,"high":20.82,"low":20.1,"amount":4444520,"amplitude":0.034351,"askPrice":20.5,"askSize":140200,"bidPrice":20.42,"bidSize":1200,"shortable":3,"etf":0,"ttmEps":1.622238335632761,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1776648600000},"marketStatusCode":7,"adr":0,"listingDate":1710864000000,"exchange":"SEHK","adjPreClose":20.96,"openAndCloseTimeList":[[1776389400000,1776398400000],[1776402000000,1776412800000]],"volumeRatio":0.3049395161802654,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02509\",,,,,undefined,":{"symbol":"02509","floatShares":225000000,"roa":"15.43%","roe":"68.31%","lyrEps":1.622238,"volumeRatio":0.3049395161802654,"shares":225000000,"dividePrice":0,"high":20.82,"amplitude":0.034351,"preClose":20.96,"low":20.1,"week52Low":8.99,"pbRate":"5.77","psRate":"4.96","week52High":36.5,"institutionHeld":0,"latestPrice":20.48,"committee":-0.983027,"eps":1.622238335632761,"divideRate":0,"volume":217800,"delay":0,"ttmEps":1.622238335632761,"open":20.82,"prevYearClose":18.78,"prevWeekClose":20.52,"prevMonthClose":19.08,"prevQuarterClose":19.08,"fiveDayClose":20.52,"twentyDayClose":18.2,"sixtyDayClose":23.3},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02509\",params:#limit:5,,,undefined,":[{"date":"2026-03-27","symbol":"02509","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774575000000,"name":null,"time":"","dateTimestamp":1774540800000,"actualEps":null},{"date":"2025-03-28","symbol":"02509","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743125400000,"name":null,"time":"盤後","dateTimestamp":1743091200000,"actualEps":null},{"date":"2024-08-15","symbol":"02509","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723685400000,"name":null,"time":"","dateTimestamp":1723651200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02509\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02509\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1769011200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02509\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02509","date":"2026-04-17","current":12.624334,"percent":0.988189,"low":-38.274716,"twenty":-21.234144,"median":-9.610023,"eighty":-5.395876,"high":13.150203,"avg":-12.306663,"sd":9.166369,"marketCap":4599144448},"quantilePoints":[{"date":"2024-03-22","current":-9.005941,"twenty":-9.920087,"median":-9.005941,"eighty":-8.797979,"marketCap":4652400020},{"date":"2024-03-28","current":-9.367246,"twenty":-9.484937,"median":-9.005941,"eighty":-8.416995,"marketCap":4821843660},{"date":"2024-04-05","current":-8.872714,"twenty":-9.396669,"median":-8.977885,"eighty":-8.598751,"marketCap":4565907160},{"date":"2024-04-12","current":-9.165919,"twenty":-9.386227,"median":-9.126184,"eighty":-8.830039,"marketCap":4719469060},{"date":"2024-04-19","current":-9.074252,"twenty":-9.304842,"median":-9.125412,"eighty":-8.934406,"marketCap":4668281760},{"date":"2024-04-26","current":-9.882424,"twenty":-9.513374,"median":-9.232059,"eighty":-8.994719,"marketCap":5077780160},{"date":"2024-05-03","current":-10.208268,"twenty":-9.517937,"median":-9.234052,"eighty":-9.046928,"marketCap":5241579520},{"date":"2024-05-10","current":-10.950727,"twenty":-10.058378,"median":-9.328243,"eighty":-9.081967,"marketCap":6018140360},{"date":"2024-05-17","current":-11.513141,"twenty":-10.522167,"median":-9.424295,"eighty":-9.09098,"marketCap":6317937020},{"date":"2024-05-24","current":-11.397533,"twenty":-11.287555,"median":-9.513128,"eighty":-9.098359,"marketCap":6240211960},{"date":"2024-05-31","current":-10.960491,"twenty":-11.380385,"median":-9.702863,"eighty":-9.110289,"marketCap":6007036780},{"date":"2024-06-07","current":-9.736726,"twenty":-11.329803,"median":-9.882424,"eighty":-9.125257,"marketCap":5329718400},{"date":"2024-06-14","current":-9.786262,"twenty":-11.239813,"median":-9.736726,"eighty":-9.134131,"marketCap":5351925560},{"date":"2024-06-21","current":-11.51586,"twenty":-11.394726,"median":-9.834343,"eighty":-9.179147,"marketCap":6284626280},{"date":"2024-06-28","current":-7.449742,"twenty":-11.394726,"median":-9.882424,"eighty":-9.134131,"marketCap":4063910280},{"date":"2024-07-05","current":-8.013266,"twenty":-11.3835,"median":-9.736726,"eighty":-9.096784,"marketCap":4370369088},{"date":"2024-07-12","current":-8.782148,"twenty":-11.375713,"median":-9.612459,"eighty":-8.973485,"marketCap":4796746560},{"date":"2024-07-19","current":-8.033889,"twenty":-11.260937,"median":-9.536435,"eighty":-8.759388,"marketCap":4388134816},{"date":"2024-07-26","current":-8.627957,"twenty":-11.24224,"median":-9.513744,"eighty":-8.627957,"marketCap":4730125080},{"date":"2024-08-02","current":-9.119354,"twenty":-11.155317,"median":-9.51436,"eighty":-8.659337,"marketCap":4996611000},{"date":"2024-08-09","current":-9.602516,"twenty":-11.096166,"median":-9.502501,"eighty":-8.759388,"marketCap":5296407660},{"date":"2024-08-16","current":-9.659156,"twenty":-11.082764,"median":-9.523303,"eighty":-8.782148,"marketCap":5329718400},{"date":"2024-08-23","current":-11.457751,"twenty":-11.24224,"median":-9.560506,"eighty":-8.785621,"marketCap":5274200500},{"date":"2024-08-30","current":-11.261539,"twenty":-11.260937,"median":-9.602516,"eighty":-8.853804,"marketCap":5218682600},{"date":"2024-09-06","current":-12.381731,"twenty":-11.301814,"median":-9.616314,"eighty":-8.872714,"marketCap":5740550860},{"date":"2024-09-13","current":-12.966504,"twenty":-11.41285,"median":-9.666597,"eighty":-8.919616,"marketCap":5995933200},{"date":"2024-09-20","current":-13.175636,"twenty":-11.495182,"median":-9.727036,"eighty":-8.943786,"marketCap":6129176160},{"date":"2024-09-27","current":-11.412309,"twenty":-11.503472,"median":-9.834343,"eighty":-8.968754,"marketCap":5340821980},{"date":"2024-10-04","current":-10.630177,"twenty":-11.500266,"median":-9.955419,"eighty":-8.992959,"marketCap":4952196680},{"date":"2024-10-10","current":-9.640046,"twenty":-11.496891,"median":-9.984689,"eighty":-9.012278,"marketCap":4463639160},{"date":"2024-10-18","current":-7.823087,"twenty":-11.483911,"median":-9.882424,"eighty":-8.891475,"marketCap":3602001352},{"date":"2024-10-25","current":-6.637022,"twenty":-11.464072,"median":-9.731881,"eighty":-8.768492,"marketCap":3055705216},{"date":"2024-11-01","current":-6.266219,"twenty":-11.439791,"median":-9.666597,"eighty":-8.552796,"marketCap":2886930800},{"date":"2024-11-08","current":-6.11978,"twenty":-11.412634,"median":-9.628889,"eighty":-8.354641,"marketCap":2798102160},{"date":"2024-11-15","current":-4.903744,"twenty":-11.406399,"median":-9.610023,"eighty":-8.146037,"marketCap":2225157432},{"date":"2024-11-22","current":-4.446271,"twenty":-11.39192,"median":-9.574881,"eighty":-7.917147,"marketCap":2016410128},{"date":"2024-11-29","current":-5.262129,"twenty":-11.380385,"median":-9.536435,"eighty":-7.700796,"marketCap":2385048984},{"date":"2024-12-06","current":-5.795133,"twenty":-11.346153,"median":-9.513744,"eighty":-7.24659,"marketCap":2620444880},{"date":"2024-12-13","current":-4.23234,"twenty":-11.292835,"median":-9.462151,"eighty":-6.614509,"marketCap":1912036476},{"date":"2024-12-20","current":-3.65763,"twenty":-11.272236,"median":-9.353096,"eighty":-6.423955,"marketCap":1643329840},{"date":"2024-12-27","current":-3.704989,"twenty":-11.261539,"median":-9.289241,"eighty":-6.377951,"marketCap":1663316284},{"date":"2025-01-03","current":-3.459219,"twenty":-11.261057,"median":-9.234052,"eighty":-6.353973,"marketCap":1554501200},{"date":"2025-01-10","current":-3.422771,"twenty":-11.250301,"median":-9.146052,"eighty":-6.232964,"marketCap":1532294040},{"date":"2025-01-17","current":-3.325837,"twenty":-11.24332,"median":-9.119354,"eighty":-5.607796,"marketCap":1490100436},{"date":"2025-01-24","current":-3.940539,"twenty":-11.188065,"median":-9.092192,"eighty":-5.378133,"marketCap":1776572800},{"date":"2025-01-28","current":-4.706176,"twenty":-11.17068,"median":-9.087355,"eighty":-5.266211,"marketCap":2131887360},{"date":"2025-02-07","current":-3.301677,"twenty":-11.154739,"median":-9.066381,"eighty":-4.958001,"marketCap":1487879720},{"date":"2025-02-14","current":-3.418254,"twenty":-11.143754,"median":-8.989713,"eighty":-4.539173,"marketCap":1536735472},{"date":"2025-02-21","current":-3.43891,"twenty":-11.106485,"median":-8.919616,"eighty":-4.354459,"marketCap":1554501200},{"date":"2025-02-28","current":-3.351703,"twenty":-11.093486,"median":-8.819713,"eighty":-4.122814,"marketCap":1510086880},{"date":"2025-03-07","current":-3.387392,"twenty":-11.071174,"median":-8.759388,"eighty":-3.975573,"marketCap":1532294040},{"date":"2025-03-14","current":-5.398225,"twenty":-11.023325,"median":-8.622598,"eighty":-3.975573,"marketCap":2442787600},{"date":"2025-03-21","current":-4.408646,"twenty":-11.005989,"median":-8.475358,"eighty":-3.996365,"marketCap":1994202968},{"date":"2025-03-28","current":-4.427424,"twenty":-10.958538,"median":-8.354936,"eighty":-4.069456,"marketCap":1998644400},{"date":"2025-04-03","current":-5.532239,"twenty":-10.950727,"median":-8.251895,"eighty":-4.071454,"marketCap":1987540820},{"date":"2025-04-11","current":-5.176788,"twenty":-10.949179,"median":-8.134698,"eighty":-4.113712,"marketCap":1843194280},{"date":"2025-04-17","current":-5.605956,"twenty":-10.931954,"median":-8.013266,"eighty":-4.15012,"marketCap":1998644400},{"date":"2025-04-25","current":-6.813611,"twenty":-10.860673,"median":-7.855635,"eighty":-4.203093,"marketCap":2433904736},{"date":"2025-05-02","current":-6.97286,"twenty":-10.741685,"median":-7.823087,"eighty":-4.240312,"marketCap":2496084784},{"date":"2025-05-09","current":-6.850326,"twenty":-10.62989,"median":-7.688151,"eighty":-4.256936,"marketCap":2469436192},{"date":"2025-05-16","current":-6.660384,"twenty":-10.625613,"median":-7.362552,"eighty":-4.28571,"marketCap":2420580440},{"date":"2025-05-23","current":-6.920763,"twenty":-10.596701,"median":-7.188701,"eighty":-4.327055,"marketCap":2522733376},{"date":"2025-05-30","current":-6.975387,"twenty":-10.531077,"median":-7.035719,"eighty":-4.335168,"marketCap":2553823400},{"date":"2025-06-06","current":-8.954176,"twenty":-10.530643,"median":-7.056435,"eighty":-4.354459,"marketCap":3286659680},{"date":"2025-06-13","current":-10.1118,"twenty":-10.525842,"median":-7.245424,"eighty":-4.362058,"marketCap":3713037152},{"date":"2025-06-20","current":-9.295434,"twenty":-10.49786,"median":-7.449742,"eighty":-4.377592,"marketCap":3406578344},{"date":"2025-06-27","current":-9.088195,"twenty":-10.44408,"median":-7.654473,"eighty":-4.399074,"marketCap":3339956864},{"date":"2025-07-04","current":-9.256954,"twenty":-10.441448,"median":-7.771425,"eighty":-4.408646,"marketCap":3402136912},{"date":"2025-07-11","current":-9.278386,"twenty":-10.438605,"median":-7.855635,"eighty":-4.408983,"marketCap":3406578344},{"date":"2025-07-18","current":-10.375245,"twenty":-10.375245,"median":-8.023578,"eighty":-4.415927,"marketCap":3806307224},{"date":"2025-07-25","current":-11.242346,"twenty":-10.444738,"median":-8.163045,"eighty":-4.427424,"marketCap":4139414624},{"date":"2025-08-01","current":-12.956889,"twenty":-10.531115,"median":-8.317696,"eighty":-4.446271,"marketCap":4741228660},{"date":"2025-08-08","current":-12.531071,"twenty":-10.816023,"median":-8.356409,"eighty":-4.497422,"marketCap":4596882120},{"date":"2025-08-15","current":-13.616918,"twenty":-10.950727,"median":-8.486422,"eighty":-4.706176,"marketCap":4987728136},{"date":"2025-08-22","current":-28.922954,"twenty":-11.024815,"median":-8.611071,"eighty":-4.860396,"marketCap":6035906088},{"date":"2025-08-29","current":-26.076607,"twenty":-11.152426,"median":-8.643647,"eighty":-4.89511,"marketCap":5467884128},{"date":"2025-09-05","current":-27.424941,"twenty":-11.24224,"median":-8.759388,"eighty":-4.895913,"marketCap":5744911480},{"date":"2025-09-12","current":-33.976118,"twenty":-11.261539,"median":-8.783884,"eighty":-4.903744,"marketCap":7130048240},{"date":"2025-09-19","current":-32.137812,"twenty":-11.3835,"median":-8.872714,"eighty":-4.920955,"marketCap":6739485088},{"date":"2025-09-26","current":-31.917438,"twenty":-11.446602,"median":-8.942813,"eighty":-4.93749,"marketCap":6675905040},{"date":"2025-10-03","current":-36.693474,"twenty":-11.494681,"median":-8.957754,"eighty":-4.939756,"marketCap":7693185808},{"date":"2025-10-10","current":-31.866218,"twenty":-11.50418,"median":-8.989713,"eighty":-4.971797,"marketCap":6671363608},{"date":"2025-10-17","current":-31.02267,"twenty":-11.536491,"median":-9.052042,"eighty":-5.060821,"marketCap":6489706328},{"date":"2025-10-24","current":-25.824743,"twenty":-11.67702,"median":-9.080681,"eighty":-5.119056,"marketCap":5404304080},{"date":"2025-10-31","current":-23.597698,"twenty":-11.854109,"median":-9.087898,"eighty":-5.129572,"marketCap":4945619448},{"date":"2025-11-07","current":-20.869587,"twenty":-12.197299,"median":-9.096784,"eighty":-5.138538,"marketCap":4371128300},{"date":"2025-11-14","current":-22.685433,"twenty":-12.458841,"median":-9.113568,"eighty":-5.155799,"marketCap":4764920384},{"date":"2025-11-21","current":-21.57415,"twenty":-12.521958,"median":-9.126184,"eighty":-5.17154,"marketCap":4529392000},{"date":"2025-11-28","current":-24.204574,"twenty":-12.94929,"median":-9.16505,"eighty":-5.177501,"marketCap":5100095392},{"date":"2025-12-05","current":-22.466634,"twenty":-13.164946,"median":-9.191702,"eighty":-5.178705,"marketCap":4742036512},{"date":"2025-12-12","current":-22.1097,"twenty":-13.511538,"median":-9.209948,"eighty":-5.212195,"marketCap":4675330264},{"date":"2025-12-19","current":-20.041803,"twenty":-17.63398,"median":-9.232059,"eighty":-5.270292,"marketCap":4248039442},{"date":"2025-12-24","current":-19.36285,"twenty":-19.558586,"median":-9.239461,"eighty":-5.282537,"marketCap":4116913158},{"date":"2026-01-02","current":-20.737965,"twenty":-19.704926,"median":-9.253177,"eighty":-5.315175,"marketCap":4426642484},{"date":"2026-01-09","current":-23.204245,"twenty":-20.357213,"median":-9.278386,"eighty":-5.378549,"marketCap":4965417516},{"date":"2026-01-16","current":-24.098803,"twenty":-20.760618,"median":-9.31719,"eighty":-5.397051,"marketCap":5173599760},{"date":"2026-01-23","current":-22.922252,"twenty":-21.536475,"median":-9.368149,"eighty":-5.401271,"marketCap":4916293200},{"date":"2026-01-30","current":-21.794057,"twenty":-21.687913,"median":-9.424295,"eighty":-5.425026,"marketCap":4695690300},{"date":"2026-02-06","current":-20.334967,"twenty":-21.659361,"median":-9.513128,"eighty":-5.511946,"marketCap":4392431440},{"date":"2026-02-13","current":-21.335749,"twenty":-21.659361,"median":-9.528371,"eighty":-5.55032,"marketCap":4635075264},{"date":"2026-02-20","current":-20.973148,"twenty":-21.649543,"median":-9.534937,"eighty":-5.562312,"marketCap":4549739576},{"date":"2026-02-27","current":-17.376769,"twenty":-21.609505,"median":-9.566812,"eighty":-5.593401,"marketCap":3810912172},{"date":"2026-03-06","current":-17.920587,"twenty":-21.564731,"median":-9.594832,"eighty":-5.599011,"marketCap":3898493536},{"date":"2026-03-13","current":-18.300829,"twenty":-21.488875,"median":-9.614895,"eighty":-5.602974,"marketCap":3999548956},{"date":"2026-03-20","current":-18.380704,"twenty":-21.336069,"median":-9.649601,"eighty":-5.606602,"marketCap":4001794632},{"date":"2026-03-27","current":-20.040776,"twenty":-21.318389,"median":-9.681606,"eighty":-5.612646,"marketCap":4352120088},{"date":"2026-04-02","current":12.478766,"twenty":-21.24895,"median":-9.659156,"eighty":-5.598207,"marketCap":4464403888},{"date":"2026-04-10","current":12.781914,"twenty":-21.241413,"median":-9.628889,"eighty":-5.5458,"marketCap":4608127152},{"date":"2026-04-17","current":12.751644,"twenty":-21.234144,"median":-9.610023,"eighty":-5.395876,"marketCap":4599144448}],"updateTime":1776479901040},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02509\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2607808070","title":"荃信生物-B(02509)1月29日斥資75.22萬港元回購3.5萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2607808070","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607808070?lang=zh_tw&edition=fundamental","pubTime":"2026-01-29 21:16","pubTimestamp":1769692617,"startTime":"0","endTime":"0","summary":"智通财经APP讯,荃信生物-B(02509)发布公告,于2026年1月29日斥资75.22万港元回购3.5万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399403.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607726789","title":"每日沽空追蹤 | 荃信生物-B 01月28日沽空量成交3000股,沽空比例為0.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607726789","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607726789?lang=zh_tw&edition=fundamental","pubTime":"2026-01-28 16:30","pubTimestamp":1769589031,"startTime":"0","endTime":"0","summary":"荃信生物-B北京时间01月28日,涨1.29%,卖空量成交3000股,较上一交易日增加66.67%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128164712a45f8af5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128164712a45f8af5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606842747","title":"荃信生物-B(02509)1月27日斥資31.98萬港元回購1.46萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2606842747","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606842747?lang=zh_tw&edition=fundamental","pubTime":"2026-01-27 21:02","pubTimestamp":1769518965,"startTime":"0","endTime":"0","summary":"智通财经APP讯,荃信生物-B(02509)发布公告,于2026年1月27日斥资31.98万港元回购1.46万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1398187.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02509","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606206727","title":"2025年中國創新藥對外授權交易額超1300億美元創紀錄","url":"https://stock-news.laohu8.com/highlight/detail?id=2606206727","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606206727?lang=zh_tw&edition=fundamental","pubTime":"2026-01-27 15:31","pubTimestamp":1769499062,"startTime":"0","endTime":"0","summary":"2025年,中国创新药对外授权交易总金额超过1300亿美元,交易数量逾150笔,占全球总量约40%,创下历史新高。阿斯利康在2025年3月初宣布25亿美元投资计划,涵盖三项BD交易及一笔收购。辉瑞与三生制药于2025年5月达成的交易刷新中国创新药出海首付款纪录,达12.5亿美元;礼来全部4笔交易均为技术平台合作,其中2笔涉及晶泰控股与英硅智能。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127153959a6b1f6d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127153959a6b1f6d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01093","BK1161","01276","01801","03692","02509","06978","02142","03696","01530","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606727819","title":"智通港股回購統計|1月27日","url":"https://stock-news.laohu8.com/highlight/detail?id=2606727819","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606727819?lang=zh_tw&edition=fundamental","pubTime":"2026-01-27 09:10","pubTimestamp":1769476202,"startTime":"0","endTime":"0","summary":"其中,回购金额最大的为小米集团-W,回购数量398.72 万,回购金额1.40 亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1397700.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02598","06831","01773","09676","00175","02382","HXXD.SI","02416","06098","02652","01600","02235","02419","02431","08017","BK1144","02586","02509","02400","01373","00103","00697","01618","02347","LU0823413587.USD","00732","02566","EVS.SI","01358","00711","01995","LU0307460666.USD","08128","81810","02158","01066","80175","09922","02392","02167","02621","MIUmain","02587","09666","GELYY","00345","09896","02556"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2606210011","title":"荃信生物-B(02509)1月26日耗資約195.28萬港元回購8.96萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2606210011","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606210011?lang=zh_tw&edition=fundamental","pubTime":"2026-01-26 20:53","pubTimestamp":1769432027,"startTime":"0","endTime":"0","summary":"智通财经APP讯,荃信生物-B(02509)公布,2026年1月26日耗资约195.28万港元回购8.96万股股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1397554.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606298228","title":"第一批NewCo,正在交卷","url":"https://stock-news.laohu8.com/highlight/detail?id=2606298228","media":"投资界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606298228?lang=zh_tw&edition=fundamental","pubTime":"2026-01-26 16:55","pubTimestamp":1769417756,"startTime":"0","endTime":"0","summary":"荃信第二次出海计划,原本也是通过NewCo的方式快速对外授权TSLP/IL-33双抗。和MNC的BD交易带给中国药企的加成,无疑是超过NewCo的。更多NewCo依然行走在融资、临床的常规节奏中。对一些资产临近临床、数据即将读出的NewCo而言,若结果积极,很可能会走向在纳斯达克上市或者被收购。彭巍透露,随着美股IPO窗口预期回暖,一批蓄势待发的公司,包括部分基于优质中国资产的NewCo,有望迎来上市的契机。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126171312a456ecc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126171312a456ecc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0359202008.SGD","LU1023057109.AUD","BK1191","LU0359201885.HKD","02509","LU2543165471.USD","LU0359201612.USD","01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606060342","title":"每日沽空追蹤 | 荃信生物-B 01月26日沽空量成交1200股,沽空比例為0.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606060342","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606060342?lang=zh_tw&edition=fundamental","pubTime":"2026-01-26 16:30","pubTimestamp":1769416232,"startTime":"0","endTime":"0","summary":"荃信生物-B北京时间01月26日,跌0.73%,卖空量成交1200股,较上一交易日减少60%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126164004a6ad76af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126164004a6ad76af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02509","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605640700","title":"每日沽空追蹤 | 荃信生物-B 01月23日沽空量成交2000股,沽空比例為0.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605640700","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605640700?lang=zh_tw&edition=fundamental","pubTime":"2026-01-23 16:30","pubTimestamp":1769157031,"startTime":"0","endTime":"0","summary":"荃信生物-B北京时间01月23日,跌5.94%,卖空量成交2000股,较上一交易日增加900%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123163926a6a44c99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123163926a6a44c99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02509","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605411964","title":"荃信生物-B(02509)出現大手賣出45萬股,成交價$20.0,涉資900萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2605411964","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605411964?lang=zh_tw&edition=fundamental","pubTime":"2026-01-23 09:00","pubTimestamp":1769130000,"startTime":"0","endTime":"0","summary":"[大手成交]荃信生物-B(02509)在上午09:00出现大手卖出,成交量为45万,成交价为港币$20.0,涉资900万。至目前为止,股价无升跌,今日最高价为$20.0,而最低价为$20.0,总成交量为45万股,总成交金额港币$900万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145550051_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145550051_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2601231/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2601231/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605102314","title":"荃信生物-B(02509)1月21日斥資98.88萬港元回購4.4萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2605102314","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605102314?lang=zh_tw&edition=fundamental","pubTime":"2026-01-21 20:51","pubTimestamp":1768999894,"startTime":"0","endTime":"0","summary":"智通财经APP讯,荃信生物-B(02509)发布公告,于2026年1月21日该公司斥资98.88万港元回购4.4万股,回购价格为每股22.08-22.50港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1395826.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605485075","title":"每日沽空追蹤 | 荃信生物-B 01月21日沽空量成交1600股,沽空比例為0.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605485075","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605485075?lang=zh_tw&edition=fundamental","pubTime":"2026-01-21 16:30","pubTimestamp":1768984234,"startTime":"0","endTime":"0","summary":"荃信生物-B北京时间01月21日,涨3.79%,卖空量成交1600股,较上一交易日增加33.33%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121165641a69b853a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121165641a69b853a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605112163","title":"中金:首予荃信生物-B(02509)跑贏行業評級 目標價33.00港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605112163","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605112163?lang=zh_tw&edition=fundamental","pubTime":"2026-01-21 10:36","pubTimestamp":1768963013,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,中金发布研报称,预计荃信生物-B2025~2027年EPS分别为1.61元、0.88元、0.55元。该行首次覆盖给予跑赢行业评级,基于DCF估值,该行给予目标价33.0港元,较公司当前股价存在41.6%的上行空间。QX001S是国内首个获批上市的乌司奴单抗生物类似药,QX005N、QX002N、QX004N均已处于III期临床阶段,有望未来1-2年也将上市贡献业绩。该行认为这些产品可组成创新双抗矩阵,成为公司未来业绩增长的新引擎。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1395447.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604271113","title":"荃信生物-B(02509)1月20日斥資183.5萬港元回購8.4萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2604271113","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604271113?lang=zh_tw&edition=fundamental","pubTime":"2026-01-20 20:47","pubTimestamp":1768913223,"startTime":"0","endTime":"0","summary":"智通财经APP讯,荃信生物-B(02509)发布公告,于2026年1月20日斥资183.5万港元回购8.4万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260120/31957563.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108318931","title":"江蘇荃信生物醫藥(02509)回購8.4萬股股份,總額約183.53萬港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1108318931","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108318931?lang=zh_tw&edition=fundamental","pubTime":"2026-01-20 20:32","pubTimestamp":1768912358,"startTime":"0","endTime":"0","summary":"江蘇荃信生物醫藥股份有限公司于2026年1月20日发布翌日披露报表,公告当天在香港联交所回购8.4万股H股股份,约占该次变动前已发行股本的0.0373%,每股回购价格介乎每股21.62港元至22.22港元,合计付出约183.53万港元。根据公告,本次回购完成后,公司于2026年1月20日的已发行股份数目为2.25149亿股,同时库藏股数量增至192.26万股,即合并计算公司总股本维持约2.270716亿股。公司强调已遵守香港联交所上市规则及相关法例的规定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604135656","title":"荃信生物-B(02509)1月19日斥資118.18萬港元回購5.3萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2604135656","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604135656?lang=zh_tw&edition=fundamental","pubTime":"2026-01-19 20:40","pubTimestamp":1768826434,"startTime":"0","endTime":"0","summary":"智通财经APP讯,荃信生物-B(02509)发布公告,于2026年1月19日该公司斥资118.18万港元回购5.3万股,回购价格为每股21.98-23.08港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1394708.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02509","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604130771","title":"每日沽空追蹤 | 荃信生物-B 01月19日沽空量成交800股,沽空比例為0.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604130771","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604130771?lang=zh_tw&edition=fundamental","pubTime":"2026-01-19 16:30","pubTimestamp":1768811431,"startTime":"0","endTime":"0","summary":"荃信生物-B北京时间01月19日,跌4.09%,卖空量成交800股,较上一交易日增加100%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119164208a43c275a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119164208a43c275a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604947852","title":"荃信生物的NewCo有點東西,投資人和高管層靠譜太重要了","url":"https://stock-news.laohu8.com/highlight/detail?id=2604947852","media":"Jo的随笔","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604947852?lang=zh_tw&edition=fundamental","pubTime":"2026-01-17 15:49","pubTimestamp":1768636182,"startTime":"0","endTime":"0","summary":"然而,近期荃信生物的股价开始出现明显的抬头迹象,这背后的核心变量,或许正是其 NewCo 模式下的 Caldera Therapeutics 迎来了质变。这种价值的提升,不再是基于母公司对管线的内部估值,而是基于全球顶级投资机构的外部定价,使得荃信生物通过 NewCo 持有的 Caldera 股权变得流动且极具价值,越来越值得我们关注。Caldera 的成功融资,将荃信生物的隐形资产价值推向了台前。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260117155457a4cebac9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260117155457a4cebac9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02509","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603932139","title":"荃信生物-B於1月15日斥資68.28萬港元回購2.96萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2603932139","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603932139?lang=zh_tw&edition=fundamental","pubTime":"2026-01-16 08:29","pubTimestamp":1768523340,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 荃信生物-B(02509)发布公告,于2026年1月15日,该公司斥资68.28万港元回购2.96万股股份,每股回购价23.02-23.18港元。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-01-16/doc-inhhncxf4138132.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02509","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603461239","title":"荃信生物-B(02509):QX030N/CLD-423完成I期臨床試驗首批受試者給藥 CALDERA THERAPEUTICS累計籌資1.125億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603461239","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603461239?lang=zh_tw&edition=fundamental","pubTime":"2026-01-14 22:33","pubTimestamp":1768401227,"startTime":"0","endTime":"0","summary":"智通财经APP讯,荃信生物-B 公布,靶向经临床验证的IL-23p19及TL1A通路的双特异性抗体QX030N/CLD-423的I期健康志愿者试验已完成首批受试者给药。截至本公告日期,公司QX030N/CLD-423的合作伙伴Caldera Therapeutics, Inc. 累计完成融资1.125亿美元。于2025年4月,Caldera Therapeutics从Atlas Venture、LAV及venBio获得7500万美元的A轮融资,近期则完成由Omega Funds领投的3750万美元A-1轮融资,参与的新投资者包括Wellington Management及Janus Henderson Investors。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1393006.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"荃信生物-B(02509):QX030N/CLD-423完成I期临床试验首批受试者给药 CALDERA THERAPEUTICS累计筹资1.125亿美元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02509","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":3,"totalSize":159,"code":"91000000","status":"200"}]}}